These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 8976503

  • 1. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
    Gallowitsch HJ, Kresnik E, Mikosch P, Pipam W, Gomez I, Lind P.
    Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
    [Abstract] [Full Text] [Related]

  • 2. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Dec; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 3. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 4. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 May; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 5. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D, Salvatori M, Casara D, Piotto A, Toniato A, Gross MD, Al-Nahhas A, Muzzio PC, Pelizzo MR.
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [Abstract] [Full Text] [Related]

  • 6. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I.
    J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
    [Abstract] [Full Text] [Related]

  • 7. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

  • 8. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.
    Küçük NO, Külak HA, Aras G.
    Ann Nucl Med; 2006 Jul; 20(6):393-7. PubMed ID: 16922467
    [Abstract] [Full Text] [Related]

  • 9. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G, Possa M, Sara R, Milella M, Rossetti C.
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [Abstract] [Full Text] [Related]

  • 10. Use of 99mTc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management.
    Wu D, Ylli D, Gomes Lima CJ, Lee W, Burman KD, Wartofsky L, Van Nostrand D.
    Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
    [Abstract] [Full Text] [Related]

  • 11. Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201.
    Adalet I, Demirkale P, Unal S, Oůz H, Alagöl F, Cantez S.
    Clin Nucl Med; 1999 Sep; 24(9):678-83. PubMed ID: 10478744
    [Abstract] [Full Text] [Related]

  • 12. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 13. Positive thyroid cancer scintigraphy using 99Tcm-tetrofosmin (Myoview): a preliminary report.
    Nĕmec J, Nývltová O, Preiningerová M, Vlcek P, Racek P, Novák Z, Blazek T, Zimák J.
    Nucl Med Commun; 1995 Aug; 16(8):694-7. PubMed ID: 7491183
    [Abstract] [Full Text] [Related]

  • 14. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
    Klain M, Maurea S, Cuocolo A, Colao A, Marzano L, Lombardi G, Salvatore M.
    Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K, Riou LM, Ruiz M, Yamamichi Y, Duatti A, Lima RL, Goode AR, Watson DD, Beller GA, Glover DK.
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [Abstract] [Full Text] [Related]

  • 16. Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinoma.
    Uğur O, Kostakoğlu L, Caner B, Güler N, Gülaldi NC, Ozmen M, Uysal U, Elahi N, Erbengi G, Bejdik C.
    Nucl Med Commun; 1996 May; 17(5):373-7. PubMed ID: 8736512
    [Abstract] [Full Text] [Related]

  • 17. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ, Houstoulaki E, Giannakenas C, Alexandrides T, Spiliotis J, Nikiforidis G, Vlachojannis JG, Vassilakos PJ.
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
    Fujie S, Okumura Y, Sato S, Akaki S, Katsui K, Himei K, Takemoto M, Kanazawa S.
    Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
    [Abstract] [Full Text] [Related]

  • 19. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
    Kosuda S, Yokoyama H, Katayama M, Yokokawa T, Kusano S, Yamamoto O.
    Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
    [Abstract] [Full Text] [Related]

  • 20. Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer.
    Aydin F, Sipahi M, Budak ES, Oner AO, Demirelli S, Erkilic M, Gungor F.
    Ann Nucl Med; 2016 Jan; 30(1):60-7. PubMed ID: 26462671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.